Terug
Dagbereik
€ 28,20
€ 30,26
52-Weeksbereik
€ 13,70
€ 36,03
Volume
117.346
50D / 200D Gem.
€ 24,16
/
€ 20,94
Vorige Slotkoers
€ 29,44
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,6 | 0,3 |
| P/B | 2,3 | 2,9 |
| ROE % | -37,8 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 60,00
+99.5%
Forward WPA
-€ 4,85
Omzet Sch.
0
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 4,19
-€ 4,19 – -€ 4,19
|
140 M | 6 |
| FY2029 |
-€ 6,29
-€ 6,29 – -€ 6,29
|
42 M | 6 |
| FY2028 |
-€ 5,61
-€ 9,35 – -€ 2,25
|
0 | 8 |
Belangrijkste Punten
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -60,29M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-37,82%
ROIC-24,95%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,01
Current Ratio26,63
Interest Coverage-1333,90
Waardering
P/E Ratio
-7,61
P/B Ratio2,25
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -74,15M |
| ROE | -37,82% | ROA | -28,41% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -60,29M |
| ROIC | -24,95% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 26,63 |
| Interest Coverage | -1333,90 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,61 | P/B Ratio | 2,25 |
| P/S Ratio | N/A | PEG Ratio | -1,69 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 564,61M | Enterprise Value | 312,09M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -74,15M | -57,98M | -42,82M | -32,18M | -8,93M |
| EPS (Diluted) | -4,05 | -3,93 | -11,53 | -29,05 | -33,36 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -84,04M | -58,02M | -44,65M | -32,83M | -15,61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 261,04M | 152,91M | 39,40M | 47,21M | 32,88M |
| Total Liabilities | 9,71M | 12,13M | 124,04M | 92,86M | 47,84M |
| Shareholders' Equity | 251,33M | 140,78M | -84,64M | -45,65M | -14,96M |
| Total Debt | 1,28M | 3,30M | 4,34M | 5,79M | 1,06M |
| Cash & Equivalents | 253,80M | 141,24M | 28,77M | 35,97M | 28,06M |
| Current Assets | 257,36M | 146,86M | 30,88M | 37,04M | 28,62M |
| Current Liabilities | 9,67M | 11,61M | 40,89M | 7,84M | 4,12M |